Mutants resistant to high levels of chloramphenicol can be obtained in Escherichia coli B by one or two mutational events. All of I44 high-level resistant mutant clones examined were powerful inactivators of the drug. Growth of this kind of mutants in nutrient media containing chloramphenicol IOO ,ug./ml. or more depended on the inoculum size, the composition of the medium, and the concentration of the drug. No growth was observed with lactose as sole energy source unless the organisms had been previously induced for P-galactosidase production.
INTRODUCTION
Resistance to chloramphenicol may be due to different mechanisms : (I) resistance of the protein synthesizing machinery (Ramsey, 1958) ; (2) decreased permeation to the site of antibiotic action (Cavalli & Maccacaro, 1952; Okamoto & Mizuno, 1962 Vazquez, 1963 Vazquez, , 1964 ; (3) inactivation of the drug (Okamoto & Suzuki, 1965 Dunsmoor, Pin & Sherris, 1963) .
Studies with Escherichia coli B and E. coli K 12 have now shown that high-level resistance to chloramphenicol in E. coli B is due to inactivation and in E. coli K 12 to impaired permeation. Inactivation of chloramphenicol has been effected also with the susceptible wild-type E. coli B, though at a slow rate, but could not be demonstrated with E. coli K 12. This is apparently a parallel to the well-known fact that penicillinase-producing mutants are never obtained from initially penicillinase-negative bacterial strains.
METHODS
Bacterial strains. ( I ) Escherichia coli 3 : the wild strain was inhibited on nutrient agar containing chloramphenicol (cm) 2.5 ,ug./ml. ; for the present work a mutant resistant to dihydrostreptomycin 5000 ,ug./ml. and sulphathiazole 40 ,ug./ml. was developed ;
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Cm-resistant mutants isolated were tested for dihydrostreptomycin and sulphathiazole resistance. (2) E. coli K 12-w 945 (lactose-, proline-, thiamine-) : this strain was inhibited by Cm 4.0 ,ug./ml. (3) E. coli K 12-w 945 : with resistance transfer factor (RTF) mediating resistance to dihydrostreptomycin, sulphathiazole, tetracycline and chloramphenicol. The RTF was transferred from a wild strain of Shigellaflexneri by using the technique of Watanabe & Fukasawa, 1961. (4) A susceptible wild strain of Shigella boydii was used for assay of chloramphenicol concentrations.
Drugs. Chloramphenicol (Cm) was obtained from Abic Ltd., Ramat-Gan, Israel.
[14C]Cm (methylene-14C) was purchased from The Radiochemical Centre, Amersham, Buckinghamshire, England; its activity was stated to be 6-81 mc/mM. Tetracycline HCl : Lederle. (Davis & Mingioli, 1950) and the same solidified with Bacto Noble Agar are designated DB and DA, respectively. The same minimal media were also used with lactose substituted fofglucose (lactose DB, lactose DA). For growth of Escherichia coli K 12-w 945, the minimal medium was supplemented with L-proline 50 mg. and thiamine HC1 I mg. per litre.
Culture media. (I)
Mutation rate was estimated by the method of Luria & Delbruck (1943). In each experiment 20-56 independent cultures grown overnight from an inoculum of about IOO bacteria were plated on DA or BAB with Cm. The mutation rate was calculated from the fraction of clones with no mutants.
Bioassay for chloramphenicol. The samples to be tested were sterilized by heating in a boiling water bath during 5 min. This procedure stopped the enzymic activity. Control samples showed no decrease in the activity of chloramphenicol due to the heating. For chloramphenicol (Cm) assay, a susceptible strain of ShigeZZa boydii was used as indicator. Samples of the test samples heated to 37' were added to cultures in the exponential phase (1.7 x 10*-2*1 x I O~ bacteriafml.). The amount added was calculated to give a final concentration of Cm 2 ,ug./ml. if no inactivation of the drug had taken place. Turbidity of the cultures was examined with a Klett Summerson photoelectric colorirneter every 20 min. during I hr. Control cultures of S. boydii in TP medium with Cm were included in each titration. The following concentrations of Cm (pg./ml.) were used in these controls: 0,0.5,1*0,2-0. From these controls a curve of generation time as a function of Cm concentration was drawn. The Cm concentration in the test samples was then determined from the generation time by interpolation.
Uptake of [14C]Cm. An exponential culture in TP medium was gathered by centrifugation to a concentration of 4 x IO'O bacteriafml. and [14C]Cm 2 ,ug./ml. added. The culture was incubated with slight shaking during 20 min. at 37", chilled, and the bacteria washed twice with 2 ml. cooled plain TP medium and once with 2 ml. distilled water. After the last deposition of the bacteria by centrifugation, I ml. of the supernatant liquid was transferred into a counting vial, and so was the sediment after resuspension. To each sample was added 15 ml. of following scintillator: 6 g. Results were correlated to the wet weight of bacteria, which was determined by centrifugation at 18,ooog for 10 min., removing the supernatant fluid and draining by tilting the test-tube on adsorbing paper. One g. wet Escherichia coli B corresponded to 6.8 x lofl bacteria.
RESULTS
Escherichia coli B mutants
Mutation rate was determined in five different experiments using media BAB and DA containing Cm 4.0 pg./ml. The results varied between 5-3 x 10-l~ and 6.7 x I O -~ mutations/bacterium/division. The degree of resistance was determined for 635 separate mutant colonies. The mutant clones were first purified by several transfers on agar medium containing Cm 4pg./ml. Heavy suspensions in broth were then streaked on BAB containing different Cm concentrations. Of the clones 578 were inhibited by Cm 8 ,ug./ml., 21 clones by 16 ,ug./ml., and 36 clones (5'7%) by 150-300 ,ug./ml. One-step high-level resistant mutants were obtained more conveniently by plating the susceptible strain on BAB containing Cm 16pg./ml. The mutation rate was in this case calculated to be 1.2 x 10-l~ mutations/bacterium/division. Of IOO mutant clones examined IOO grew when streaked on BAB with Cm ~oopg./ml. and 8 on 250 ,ug./ml. High-level resistant mutants were also isolated from low-level resistant clones (Cm 4,ug./ml.) by plating on BAB with Cm 16pg./ml. These mutations occurred at a frequency of about I ~-~/bacterium/division. It might be concluded from these experiments that Escherichia coli B may obtain low-level as well as highlevel resistance to chloramphenicol in a single mutational event.
Inactivation of chloramphenicol by Escherichia coli B. The susceptible Escherichia coli B inactivates chloramphenicol but at a very slow rate. This was shown in experiments of the following type. A TP culture was grown to the exponential growth phase and the bacteria concentrated by centrifugation to a density of 1.6 x 109 bacteria/ ml. Chloramphenicol was added to Cm ~oopg./ml. and the culture incubated for 18 hr at 37". Assay of residual Cm showed about 80 pg./ml.
On the other hand, 114 one-step and 30 two-step high-level resistant clones all proved to be powerful inactivators of Cm. In the tests with these strains, TP with Cm IOO ,ug.lml. was inoculated with about 2.0 x IO* bacteria/ml. After 18 hr incubation at 37" and centrifugation the supernatant culture fluid was assayed for Cm; none was found.
The kinetics of Cm inactivation were studied more closely in a few of the one-step high-level resistant clones. Some observations with one of the strains (Escherichia coli B/I) will be given. After addition of Cm to ~oo,ug./ml. to an exponentially growing culture of E. coli B/I in TP, more than 90% of the Cm was inactivated during 30 min. and inactivation was complete after 60 min. (Fig. I) . At this time the growth, which initially was slowed by the Cm, continued at the same rate as in the control culture. With Cm 400 ,ug./ml., 75 yo of the Cm was inactivated in 30 min., and after 120 min. inactivation was complete; however, even then growth remained slow (Fig. 2) . This problem will be dealt with elsewhere.
Inoculum size and nutrient medium. The minimal inhibitory concentration of Cm
for Escherichia coli B/I depends on the inoculum size and the nutrient medium. This is shown by observations summarized in Table I . An exponential phase culture in TP was centrifuged, the bacteria washed twice in cold phosphate buffer (pH 7-2; 0.15~) and inoculated on plain TPA as well as on TPA containing various amounts of Cm. With Cm up to 60 ,ug./ml. the colony counts were as on plain agar. However, with TPA containing Cm roo pg./ml. growth occurred only when at least 9 x 103 bacteria were seeded, but then growth was confluent as on the control plate with a similar inoculum. To obtain growth on TPA with Cm 2oopg./ml. a Iooo-fold increase in inoculum size (to 9 x 10~) was required. With this inoculum growth was confluent, though no colonies occurred on the plate inoculated with 9 x 105 bacteria. On minimal medium with glucose (DA) an' inoculum size of 9 x I O~ was required for growth in Cm IOO ,ug./ml. Of special interest was the observation that on lactose DA+Cm IOO pg./ml. no growth was obtained even with an inoculum of 9 x 1 0 ' bacteria/ml. However, when the galactosidase-system was induced by incubation with lactose (I hr), no difference was observed between growth on lactose and glucose media.
Uptake of [14C]Cm. No significant difference was noticed in the uptake of labelled Table 2) . The radioactivity/g wet wt bacteria corresponded very closely to the [W]Cm 2 ,ug./ml. initially added to the suspension of the bacteria. Even though a part of the reversibly bound Cm might have been removed by washing, it seems that no marked intracellular concentration of label had taken place, and this in spite of the fact that with the high bacterial concentration used (4 x I O~O bacteria/ml.) virtually all the Cm must have been inactivated (compare Fig. I ). It seems therefore that the turnover of Cm molecules was high, so that after 20 min. the same amount of radioactivity was found in the susceptible bacteria as in those which had inactivated about 17 times more Cm than the amount corresponding to the amount of label found.
Cross resistance to tetracycline. No resistance to tetracycline was found in 22 onestep high-level resistant mutants of Escherichia coli B. The minimal inhibitory concentration in BAB of tetracycline was I pg./ml., both for the mutants and for the susceptible ancestor.
Escherichia coli K 12 mutants Mutants were isolated by plating on BAB and DA containing chloramphenicol 8-16 pg./ml. Mutation rate varied in different experiments between 4-6 x 1 0 -l~ and
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I -3 x I o -~ mutations/bacterium/division. High-level resistance was only obtained stepwise. Four mutational events were needed for resistance to Cm 300 pg./ml.
Inactivation of chloramphenicol. Inactivation by the susceptible Escherichia coli K I 2 was examined on a TP culture concentrated to about 1.6 x 109 bacteria/ml. and In media? in the susceptible parent strain. All the resistant mutants examined grew very slowly on plain nutrient media as well as on Cm-containing media. In Fig. 3 , growth in TP (37O, with shaking) of the susceptible strain is compared with growth of one of the high-level resistant mutants (Escherichia coli K I 21 I). The shortest generation time was about 30min. for the susceptible and ~o o m i n . for the resistant strain. Growth ceased at 0.52 extinction for the susceptible strain as compared with only 0.28 for the resistant strain. Addition of Cm IOO ,ug./ml. to the culture of the resistant strain had almost no effect during the first go min.; thereafter the growth slowed down to cease entirely at 0.20 extinction. This might indicate that 'resistance' in E. coli K 12/1 was caused by decrease in the permeability of the bacteria to the drug. This assumption was confumed when the bacteria were suspended in a buffer
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solution containing Cm IOO ,ug./ml. during 120 min. before incubation in Cm+TP medium. Inhibition of growth was in this case immediate and complete (Fig. 4) .
Escherichia coli K 12 infected with resistance transfer factor (RTF). Further evidence for the assumption that permeation by chloramphenicol was delayed in E. coli K 12/1 was obtained by infecting this strain as well as its ancestor (E. coli K 12) with a resistance transfer factor from a strain of Shigella Jlexneri. The curves on Fig. 5 show the results of three experiments with Escherichia coli K I~/ R T F and E. coli K I~/ I / R T F .
Both strains were able to grow in TP containing Cm 200 ,ug./ml. Inactivation of Cm is shown in the figure as a ' semi-log' plot of active Cm against time. During the first 120 min. after addition of the drug, more than 90% was inactivated by E. coli K I~/ R T F , but only 55% by the tolerant Chloramphenicol resistance of E. coli
though the concentration of the latter organism was slightly greater than of the former. Similar kinetics of Cm inactivation by these strains were observed in an experiment with Cm ~oo,ug./ml. As inactivation displays itself intracellularly (Miyamura, 1964 ; and unpublished observation with Shigella Jlexneri and with E. coli B/RTF in our laboratory), it must depend on the rate of uptake.
Uptake of [14C] chloramphenicol. Uptake of [14C]Cm was apparently a little higher in Escherichia coli K 12 than in E. coli B. The resistant mutant E. coli K 12/1 showed a significantly lower radioactivity (1/6) than its ancestor (Table 2) .
Cross-resistance to tetracycline. The minimal inhibitory concentration of tetracycline in TPA was raised from I ,ug./ml. for the parent strain to 20 ,ug./ml. for all 22 high-level resistant clones of Escherichia coli K 12 which were examined. 
DISCUSSION
The main properties of high-level resistant mutants of Escherichia coli B and E. coli K 12 are summarized in Table 3 . All the observations can be explained by the assumption that in E. coli B resistance is due to inactivation of chloramphenicol, and in E. coli K 12 to impaired permeability. Inactivation of Cm by micro-organisms has been reported by several other authors since the first investigation by Smith & Worrel (I 949). Recent publications indicate that an oxidative process requiring acetyl co-enzyme A is responsible for inactivation in E. coli (Okamoto & Suzuki, 1965) and in Staphylococcus aureus (Suzuki, Okamoto & Kono, 1966) . The latter authors as well as Miyamura (1964) have presumed that mutants obtained in vitro will never be resistant by virtue of an inactivating ability. Our results with E. coli B contradict this. No entirely new enzyme can, of course, be formed by a mutant. Accordingly, this kind of resistance was found only in mutants of E. coli B of which the parent strain also proved to inactivate the drug, though to a slight degree. A mutation to an effective degree of inactivation might be one in which the enzyme: (I) is formed in a greater amount; (2) has a higher affinity for the substrate (Cm); (3) is constitutive instead of inducible. It should, however, be pointed out that we have not shown that inactivation of Cm by the resistant E. coli B was due to the same enzymic system as functions to a slow degree in the susceptible ancestor.
One-step mutations to high-level resistance to streptomycin are commonly observed. As far as we are aware, such single-step mutation to high-level resistance to chloramphenicol has hitherto only been reported for Mycobacterium ranae (Szybalski & Bryson, 1954) , but no data are available on the mechanism of resistance in this micro-organism.
In our case it was amply manifested that inactivation was the cause of resistance and not simply a consequence of growth in presence of chloramphenicol, as can be
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seen from the following facts. (I) After addition of Cm the growth rate was decreased until inactivation was completed (Fig. I). (2) The minimal inhibitory concentration of Cm depended on the inoculum size. (3) On Cm-containing media an all-or-none growth response occurred (Table I) . On the plate with Cm 200pg./ml. TPA, for example, confluent growth was obtained after incubation with 9.0 x 106 bacterialml. This was not due to the ability of a small fraction of the population to form colonies at this Cm concentration, since no growth occurred when the inoculum size was decreased by only one-tenth.
The inactivating enzymic system must be constitutive because otherwise the chloramphenicol would prevent its synthesis. Further, confirming the report of Merkel & Steers (1953) that glucose is required for inactivation by non-multiplying bacteria, our results show that inactivation depended on the presence of utilizable carbohydrate. On lactose medium no induction of P-galactosidase was possible, because of the Cm present, and without this enzyme no energy source was available for the inactivation. Pre-incubation with lactose unlocked this metabolic knot.
On media containing Cm ~oopg./ml. or more growth depended on very large inoculum sizes; the smallest inoculum which gave growth was 1000 times greater on minimal medium (DA) than on complex TPA medium. Miyamura et al. (1962) reported that small amounts of peptone stimulated inactivation by non-multiplying bacteria. The explanation may be that with an initial high concentration of chloramphenicol virtually all protein synthesis was blocked. Cm-inactivation was therefore limited by the amount of inactivating enzyme present in the sample of bacteria inoculated and co-factors in the bacteria and the nutrient media. On the other hand, with Cm 60 pg./ml. each bacterium of the inoculum grew to a colony, indicating that additional enzyme and/or co-factors might be synthesized de novo. This concentration of Cm may not completely prevent protein synthesis (Okamoto & Mizuno, 1962) .
Uptake of [14C]chloramphenicol is generally several times lower in resistant bacteria than in sensitive organisms of the same species (Vazquez, 1964; Unowsky & Rachmeler, 1966) . Our results with Escherichia coli K 12 confirm this; but with Escherichia coli B no difference between the susceptible ancestor and the resistant mutant was noticed. The intracellular concentration of Cm, calculated per wet wt bacteria, was near that of the medium, proving that no concentration of Cm occurred. It follows from this that entry to, inactivation, and exit from the cell of Cm molecules must occur at a great rate. From Fig. 2 it can be seen that 1.5 x 108 bacteria (I ml. at a concentration corresponding to 22 Klett units) inactivated 300pg. Cm, which is 5-6 x 1017 molecules Cm/3o min. or 2.54 x 106 molecules/bacterium/sec.
Hitherto we have not isolated mutants of the chloramphenicol-tolerant kind from Escherichia coli B, in spite of the fact that many mutant clones have been examined. With E. coli K 12, of which 36 mutants were examined, not one Cm inactivator was found. Decreased permeability to Cm was found in mutants of the latter variant of E. coli. That resistance was due to this lowered permeability was shown by the complete inhibition of growth after an incubation period in a Cm-containing buffer solution.
The decreased permeability may be non-specsc for Cm. Cross-resistance with tetracycline and puromycin (Reeve & Bishop, 1965) should not uncritically be related to common features in the action of these three antibiotics. It might well be a consequence of decreased permeability for a wide range of micromolecular species. The Chloramphenicol resistance of E. coli 65 markedly decreased growth rate in TP medium as well as in minimal medium might simply be a consequence of an unspecific permeability barrier.
The growth curve of the resistant mutant Escherichia coli K 12/1 in TP medium (Fig. 3) indicates that there must have been something more than a simple decrease in the rate of permeation, since growth ceased at a much lower population density than for the sensitive strain.
The practical aspect of resistance to chloramphenicol is outside the scope of this communication. It may, however, be mentioned that inactivation is a far more serious form of drug resistance than is the mechanism observed with E. coEi K 12, which places the micro-organism in absence of the drug at a competitive disadvantage.
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